ACTIVE SUBSTANCE / INN

FLUTICASONE FUROATE;VILANTEROL

Brand name(s): Relvar Ellipta, Revinty Ellipta
EMA LISTED
AUTHORISED
Pulmonary Disease, Chronic Obstructive
Asthma
ACTIVE SUBSTANCE
Fluticasone Furoate;Vilanterol
REGULATORS
EMA
SPONSORS / MAH
GlaxoSmithKline Trading Services Limited
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Relvar ElliptaGlaxoSmithKline Trading Services LimitedAuthorised13/11/2013Pulmonary Disease, Chronic Obstructive
Revinty ElliptaGlaxoSmithKline Trading Services LimitedAuthorised02/05/2014Asthma

FULL INTELLIGENCE ON FLUTICASONE FUROATE;VILANTEROL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →